Pattern of risks of rheumatoid arthritis among patients using statins: A cohort study with the clinical practice research datalink.
Cast your vote
You can rate an item by clicking the amount of stars they wish to award to this item.
When enough users have cast their vote on this item, the average rating will also be shown.
Your vote was cast
Thank you for your feedback
Thank you for your feedback
Authorsde Jong, Hilda J I
Cohen Tervaert, Jan Willem
de Vries, Frank
Vandebriel, Rob J
van Loveren, Henk
Klungel, Olaf H
van Staa, Tjeerd P
MetadataShow full item record
TitlePattern of risks of rheumatoid arthritis among patients using statins: A cohort study with the clinical practice research datalink.
Published inPlos One 2018; 13(2):e0193297
PubliekssamenvattingWe examined the association between statin use and the risk of rheumatoid arthritis (RA), with special focus on describing the patterns of risks of RA during statin exposure in a large population-based cohort in the United Kingdom. In the Clinical Practice Research Datalink, patients aged ≥40 years with at least one prescription of statins (1995-2009) were selected, and matched by age (+/-5 years), sex, practice and date of first prescription of statins to non-users. The follow-up period of statin use was divided into periods of current, recent and past exposure, with patients moving between these three exposure categories over time. Time-dependent Cox models were used to derive hazard ratios (HRs) of RA, adjusted for disease history and previous drug use. The study population included 1,023,240 patients, of whom 511,620 were statin users. No associations were found between RA and current (HRadj,1.06;99%CI:0.88-1.27) or past statin users (HRadj,1.18;99%CI:0.88-1.57). However, in patients who currently used statins, hazard rates were increased shortly after the first prescription of statins and then gradually decreased to baseline level. The risk of developing RA was increased in recent statin users, as compared to non-users (HRadj,1.39;99%CI:1.01-1.90). The risk of RA is substantially increased in the first year after the start of statins and then diminishes to baseline level. These findings may suggest that statins might accelerate disease onset in patients susceptible to develop RA, but in other patients, statins are probably safe and well tolerated, even after prolonged use. Alternatively, we cannot rule out that confounding by cardiovascular risk factors and ascertainment bias may have influenced the findings.
- Pattern of risks of systemic lupus erythematosus among statin users: a population-based cohort study.
- Authors: De Jong HJI, van Staa TP, Lalmohamed A, de Vries F, Vandebriel RJ, Van Loveren H, Klungel OH, Cohen Tervaert JW
- Issue date: 2017 Oct
- Statins and Risk of Rheumatoid Arthritis: A Nested Case-Control Study.
- Authors: Tascilar K, Dell'Aniello S, Hudson M, Suissa S
- Issue date: 2016 Nov
- Statins and the risk of type 2 diabetes mellitus: cohort study using the UK clinical practice pesearch datalink.
- Authors: Macedo AF, Douglas I, Smeeth L, Forbes H, Ebrahim S
- Issue date: 2014 Jul 15
- Use of statins is associated with an increased risk of rheumatoid arthritis.
- Authors: de Jong HJ, Klungel OH, van Dijk L, Vandebriel RJ, Leufkens HG, van der Laan JW, Cohen Tervaert JW, van Loveren H
- Issue date: 2012 May
- Impact of statin discontinuation on mortality in patients with rheumatoid arthritis: a population-based study.
- Authors: De Vera MA, Choi H, Abrahamowicz M, Kopec J, Lacaille D
- Issue date: 2012 Jun